Carafate

Carafate is a brand name of sucralfate, approved by the FDA in the following formulation(s):

CARAFATE (sucralfate - suspension; oral)

• 
  Manufacturer: APTALIS PHARMA US
  
  Approval date: December 16, 1993
  
  Strength(s): 1GM/10ML ^[RLD]

CARAFATE (sucralfate - tablet; oral)

• 
  Manufacturer: APTALIS PHARMA US
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 1GM ^[RLD][AB]

Has a generic version of Carafate been approved?

Yes. The following products are equivalent to Carafate:

sucralfate tablet; oral

• 
  Manufacturer: NOSTRUM LABS
  
  Approval date: June 8, 1998
  
  Strength(s): 1GM ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: March 29, 1996
  
  Strength(s): 1GM ^[AB]

Note: No generic formulation of the following product is available.

• sucralfate - suspension; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Carafate. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Carafate.

See also...

• Carafate Consumer Information (Drugs.com)
• Carafate Consumer Information (Wolters Kluwer)
• Carafate Suspension Consumer Information (Wolters Kluwer)
• Carafate Consumer Information (Cerner Multum)
• Carafate Advanced Consumer Information (Micromedex)
• Carafate AHFS DI Monographs (ASHP)
• Sucralfate Consumer Information (Wolters Kluwer)
• Sucralfate Suspension Consumer Information (Wolters Kluwer)
• Sucralfate Consumer Information (Cerner Multum)
• Sulcrate Suspension Plus Advanced Consumer Information (Micromedex)
• Sucralfate Advanced Consumer Information (Micromedex)
• Sucralfate AHFS DI Monographs (ASHP)